US Stock MarketDetailed Quotes

PSYBF PSYBIO THERAPEUTICS CORP

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 5 16:00 ET
127.54Market Cap0.00P/E (TTM)

PSYBIO THERAPEUTICS CORP Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0.00%25K
0.00%12.5K
-20.00%50K
0
1.31%12.5K
101.90%25K
0.00%12.5K
62.5K
25.72K
12.34K
Gross profit
0.00%-25K
0.00%-12.5K
20.00%-50K
0
-1.31%-12.5K
-101.90%-25K
0.00%-12.5K
-62.5K
-25.72K
-12.34K
Operating expense
-90.37%131.99K
-46.57%788.98K
-51.01%4.71M
-57.55%947.16K
-60.33%912.51K
-64.02%1.37M
6.75%1.48M
9.61M
2.23M
2.3M
Selling and administrative expenses
-90.81%105.08K
-42.10%717.18K
-55.64%3.95M
-64.36%720.24K
-57.70%845.31K
-68.71%1.14M
-7.35%1.24M
--8.9M
--2.02M
--2M
-General and administrative expense
-90.81%105.08K
-42.10%717.18K
-55.64%3.95M
-64.36%720.24K
-57.70%845.31K
-68.71%1.14M
-7.35%1.24M
--8.9M
--2.02M
--2M
Research and development costs
--0
--0
-37.36%390.14K
-18.47%151.94K
-98.91%2.95K
-4.02%131.04K
211.40%104.21K
--622.8K
--186.35K
--270.5K
Depreciation amortization depletion
--0
0.00%38.02K
--152.08K
--38.02K
--38.02K
--38.02K
--38.02K
--0
----
----
-Depreciation and amortization
--0
0.00%38.02K
--152.08K
--38.02K
--38.02K
--38.02K
--38.02K
--0
----
----
Other operating expenses
-53.40%26.91K
-64.73%33.77K
155.53%216.68K
54.62%36.96K
-16.49%26.23K
236.06%57.75K
643.51%95.75K
--84.8K
--23.9K
--31.41K
Operating profit
88.75%-156.99K
46.18%-801.48K
50.81%-4.76M
58.04%-947.16K
60.00%-925.01K
63.48%-1.39M
-6.69%-1.49M
-9.67M
-2.26M
-2.31M
Net non-operating interest income expense
0
29.22%-3.39K
-21.05K
-4.43K
-5.43K
-6.4K
-4.79K
0
Non-operating interest expense
--0
-29.22%3.39K
--21.05K
--4.43K
--5.43K
--6.4K
--4.79K
--0
----
----
Other net income (expense)
30.35%-25K
92.75%-6.62K
91.94%-108.83K
105.24%9.95K
-69.75%8.54K
-127.54%-35.9K
92.27%-91.41K
-1.35M
-189.95K
28.22K
Gain on sale of security
----
93.54%-6.62K
-411.09%-136.94K
115.69%9.94K
977.21%6.01K
-6,358.79%-50.37K
-372.77%-102.53K
---26.79K
---63.4K
--558.1993
Special income (charges)
---25K
----
--0
--0
--0
--0
----
---1.41M
---158.56K
--0
-Less:Restructuring and merger&acquisition
--0
----
--0
--0
--0
--0
----
--1.24M
--11.06K
--0
-Less:Other special charges
--25K
----
----
----
----
----
----
--176.42K
--147.51K
----
Other non- operating income (expenses)
----
----
-68.64%28.11K
-100.00%1
-90.88%2.52K
-51.60%14.48K
1,115.97%11.11K
--89.65K
--32.01K
--27.66K
Income before tax
87.34%-181.99K
48.81%-811.49K
55.66%-4.89M
61.52%-941.64K
59.65%-921.9K
62.53%-1.44M
38.52%-1.59M
-11.02M
-2.45M
-2.28M
Income tax
Net income
87.34%-181.99K
48.81%-811.49K
55.66%-4.89M
61.52%-941.64K
59.65%-921.9K
62.53%-1.44M
38.52%-1.59M
-11.02M
-2.45M
-2.28M
Net income continuous Operations
87.34%-181.99K
48.81%-811.49K
55.66%-4.89M
61.52%-941.64K
59.65%-921.9K
62.53%-1.44M
38.52%-1.59M
---11.02M
---2.45M
---2.28M
Minority interest income
Net income attributable to the parent company
87.34%-181.99K
48.81%-811.49K
55.66%-4.89M
61.52%-941.64K
59.65%-921.9K
62.53%-1.44M
38.52%-1.59M
-11.02M
-2.45M
-2.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
87.34%-181.99K
48.81%-811.49K
55.66%-4.89M
61.52%-941.64K
59.65%-921.9K
62.53%-1.44M
38.52%-1.59M
-11.02M
-2.45M
-2.28M
Basic earnings per share
0.00%-0.01
0.00%-0.01
60.00%-0.04
0
57.48%-0.01
69.00%-0.01
66.67%-0.01
-0.1
-0.0216
-0.0235
Diluted earnings per share
0.00%-0.01
0.00%-0.01
60.00%-0.04
0
57.48%-0.01
69.00%-0.01
66.67%-0.01
-0.1
-0.0216
-0.0235
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0.00%25K0.00%12.5K-20.00%50K01.31%12.5K101.90%25K0.00%12.5K62.5K25.72K12.34K
Gross profit 0.00%-25K0.00%-12.5K20.00%-50K0-1.31%-12.5K-101.90%-25K0.00%-12.5K-62.5K-25.72K-12.34K
Operating expense -90.37%131.99K-46.57%788.98K-51.01%4.71M-57.55%947.16K-60.33%912.51K-64.02%1.37M6.75%1.48M9.61M2.23M2.3M
Selling and administrative expenses -90.81%105.08K-42.10%717.18K-55.64%3.95M-64.36%720.24K-57.70%845.31K-68.71%1.14M-7.35%1.24M--8.9M--2.02M--2M
-General and administrative expense -90.81%105.08K-42.10%717.18K-55.64%3.95M-64.36%720.24K-57.70%845.31K-68.71%1.14M-7.35%1.24M--8.9M--2.02M--2M
Research and development costs --0--0-37.36%390.14K-18.47%151.94K-98.91%2.95K-4.02%131.04K211.40%104.21K--622.8K--186.35K--270.5K
Depreciation amortization depletion --00.00%38.02K--152.08K--38.02K--38.02K--38.02K--38.02K--0--------
-Depreciation and amortization --00.00%38.02K--152.08K--38.02K--38.02K--38.02K--38.02K--0--------
Other operating expenses -53.40%26.91K-64.73%33.77K155.53%216.68K54.62%36.96K-16.49%26.23K236.06%57.75K643.51%95.75K--84.8K--23.9K--31.41K
Operating profit 88.75%-156.99K46.18%-801.48K50.81%-4.76M58.04%-947.16K60.00%-925.01K63.48%-1.39M-6.69%-1.49M-9.67M-2.26M-2.31M
Net non-operating interest income expense 029.22%-3.39K-21.05K-4.43K-5.43K-6.4K-4.79K0
Non-operating interest expense --0-29.22%3.39K--21.05K--4.43K--5.43K--6.4K--4.79K--0--------
Other net income (expense) 30.35%-25K92.75%-6.62K91.94%-108.83K105.24%9.95K-69.75%8.54K-127.54%-35.9K92.27%-91.41K-1.35M-189.95K28.22K
Gain on sale of security ----93.54%-6.62K-411.09%-136.94K115.69%9.94K977.21%6.01K-6,358.79%-50.37K-372.77%-102.53K---26.79K---63.4K--558.1993
Special income (charges) ---25K------0--0--0--0-------1.41M---158.56K--0
-Less:Restructuring and merger&acquisition --0------0--0--0--0------1.24M--11.06K--0
-Less:Other special charges --25K--------------------------176.42K--147.51K----
Other non- operating income (expenses) ---------68.64%28.11K-100.00%1-90.88%2.52K-51.60%14.48K1,115.97%11.11K--89.65K--32.01K--27.66K
Income before tax 87.34%-181.99K48.81%-811.49K55.66%-4.89M61.52%-941.64K59.65%-921.9K62.53%-1.44M38.52%-1.59M-11.02M-2.45M-2.28M
Income tax
Net income 87.34%-181.99K48.81%-811.49K55.66%-4.89M61.52%-941.64K59.65%-921.9K62.53%-1.44M38.52%-1.59M-11.02M-2.45M-2.28M
Net income continuous Operations 87.34%-181.99K48.81%-811.49K55.66%-4.89M61.52%-941.64K59.65%-921.9K62.53%-1.44M38.52%-1.59M---11.02M---2.45M---2.28M
Minority interest income
Net income attributable to the parent company 87.34%-181.99K48.81%-811.49K55.66%-4.89M61.52%-941.64K59.65%-921.9K62.53%-1.44M38.52%-1.59M-11.02M-2.45M-2.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 87.34%-181.99K48.81%-811.49K55.66%-4.89M61.52%-941.64K59.65%-921.9K62.53%-1.44M38.52%-1.59M-11.02M-2.45M-2.28M
Basic earnings per share 0.00%-0.010.00%-0.0160.00%-0.04057.48%-0.0169.00%-0.0166.67%-0.01-0.1-0.0216-0.0235
Diluted earnings per share 0.00%-0.010.00%-0.0160.00%-0.04057.48%-0.0169.00%-0.0166.67%-0.01-0.1-0.0216-0.0235
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.